Eli Lilly & Co: Barrett Brian

Eli Lilly & Co has garnered mixed reviews from patients regarding their diabetes medications, particularly Mounjaro and Trulicity. While some users report successful management of their diabetes with these medications, others express frustration over accessibility issues and production interruptions, emphasizing the critical need for these treatments. Overall, patients appreciate the effectiveness of the medications when available, but many are calling for improvements in distribution and support to ensure that those who rely on them can access their necessary treatments consistently.